Skip to content

HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States

Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03628235
Enrollment
233
Registered
2018-08-14
Start date
2020-06-21
Completion date
2022-06-21
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Huntington's Disease

Keywords

online survey, indirect costs, out-of-pocket costs, HD, Huntington's disease, companions, Enroll-HD

Brief summary

Huntington's disease (HD) is a rare, inherited and progressive neurodegenerative disorder for which hallmark symptoms include movement disorders, loss of cognitive faculties and psychiatric disturbances. With the progression of the disease, patients require increasing level of medical care, caregiver support, and long-term care, which lead to substantial burden of illness. Very little data are available on the direct or indirect costs for HD. The direct medical costs of HD in the US have been summarized from retrospective commercial and Medicaid claims data analysis. The indirect and out-of-pocket costs of HD in the US have not been quantified. This study will help to bridge these gaps. This study is a single-assessment, cross-sectional online survey administered to Huntington disease gene expansion carriers (HDGECs) and companions of HDGECs by HD stage to understand the indirect and out-of-pocket costs of Huntington's disease in the US.

Detailed description

The survey collects the following data from each HDGEC and companion: 1. Participant demographics (for HDGECs and companion) 2. Informal care received (for HDGECs only) 3. Out of pocket HD costs (for HDGECs and companion) 4. Current employment status (for HDGECs and companion) 5. Non-work and work care giving time that companion spends taking care of HDGEC (for companion only) 6. Work Productivity and Activity Impairment (WPAI) Questionnaire (for HDGECs and companion)

Interventions

BEHAVIORALOnline survey

Online survey to capture indirect and out of pocket costs of Huntington's Disease in HDGECs and companions

Sponsors

IQVIA Company
CollaboratorUNKNOWN
CHDI Foundation, Inc.
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

for HDGECs: * Identified as an active participant in Enroll-HD (participants who have completed their last on site Enroll-HD visit within approximately 15 months) * Able to provide online or written informed consent. A LAR for HDGEC can provide written consent, if applicable * Identified as a participant with clinically diagnosed HD and has a CAG length ≥ 40 * Site PI has access to HDGEC's medical records for the purpose of completing the Resource Utilization Questionnaire * Able to speak and understand both verbal and written English * Has adult onset of disease (disease symptoms manifested at age 20 years or older) * Has access to a computer/tablet/smartphone (if compatible) and internet services Stage classification of HDGECs: 1. Early stage HDGEC: CAG length ≥ 40; DCL = 4, TFC ≥ 11 2. Middle stage HDGEC: CAG length ≥ 40; DCL = 4, 7 ≤ TFC ≤ 10 3. Late stage HDGEC: CAG length ≥ 40; DCL = 4, 0 ≤ TFC ≤ 6

Exclusion criteria

for HDGECs: HDGECs will be excluded from the study if they have significant cognitive or any other impairment sufficient to interfere with study associated tasks as judged by the Site PI or Site PI's designee (exceptions will be made if a companion/LAR completes the survey on their behalf). Inclusion criteria for companions: * Able to provide online or written informed consent * Identified as the primary provider (unpaid) of supportive care of an HDGEC (HDGEC must be an Enroll-HD participant and have a CAG length ≥ 40 and have adult onset of disease (disease symptoms manifested at age 20 years or older)) * Able to speak and understand both verbal and written English * Aged 21 years or older at time of survey * Has access to a computer/tablet/smartphone (if compatible) and internet services and has the technical skills required to complete an online survey

Design outcomes

Primary

MeasureTime frameDescription
Quantify the indirect costs associated with productivity loss for HDGECs and companions12 monthsProductivity loss is measured by annual lost wages and it is collected in the survey's employment questionnaires and WPAI
Quantify out-of-pocket expenses for HDGECs and companions12 monthsThe indirect costs associated with the total annual out-of-pocket expenses.
Identify the indirect costs associated with informal care received for HDGECs12 monthsThe total informal care time received during a typical week
Quantify the indirect costs associated with non-work caregiving time for companions12 monthsThe indirect costs associated with the annual opportunity costs of companion

Secondary

MeasureTime frameDescription
The proportion of Dual Role Companions, differentiated by HD stage of the companion12 months
To understand traditional disease staging system based on total functional capacity (TFC)12 monthsFor HDGECs and Companions: Understand how the traditional disease staging system, based on the TFC score, relates to a staging system based on resource utilization questionnaire and comorbid conditions developed in Divino et al. (2013)
Identify the reasons for HDGEC and companion's unemployment or underemployment12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026